Repeated Radiosynovectomy in Haemophilia: Revealing Long‐Term Effectiveness and Safety
Haemophilia · 2025
DOI: 10.1111/hae.15142 ↗Kurz gefasst
Fachartikel in der Zeitschrift Haemophilia, 2025. Verfasst von Basak Koc und 3 weiteren Autor:innen. Beteiligte Einrichtung: Hereditary Bleeding Disorders Unit, Istanbul University Oncology Institute, Istanbul, Turkey. Hauptthemen laut MEDLINE: Hemophilia A. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Introduction
Radiosynovectomy (RS), which uses beta particle‐emitting radiocolloids, has proven highly effective in significantly reducing the occurrence of haemarthroses and breaking the cycle of bleeding and synovitis. This study now presents the long‐term outcomes of repeated RS in individuals with haemophilia. Materials and Methods Repeated RS was administered to 48 joints in 37 people with haemophilia (PwHs) diagnosed with chronic haemophilic synovitis. The frequency of bleeding episodes was meticulously recorded during the 6‐month periods preceding and following each of the initial and subsequent RS procedures. Treatment failure was designated by the necessity for additional RS injections.
Results
The results for 48 joints were analysed. The mean bleeding frequency of the joints was 12.5 ± 7.29 (median 10) within the last 6 months in the pre‐treatment evaluation and after the treatment, the mean bleeding frequency of the joints decreased to 2.25 ± 3.82 (median 0.5) for the first 6 months ( p < 0.001) after the first RS. The mean survival of the first intervention was 40.52 ± 33.79 months (range, 1–124 months). In the second RS, the mean bleeding frequency of the joints was 10.29 ± 7.66 (median 8) within the last 6 months in the pre‐treatment evaluation and after the treatment, and the mean bleeding frequency of the joints decreased to 0.93 ± 1.69 (median 0) for the first 6 months ( p < 0.001). The survival rate of the second RS was 94% at 12 months, and 87% at 36 months.
Conclusion
Repeated RS was proven to be an effective and safe treatment for Pwh with recurrent bleeding episodes during long‐term follow up. Thirty‐six months survival rate was 87% (42 of 48 joints).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hereditary Bleeding Disorders Unit, Istanbul University Oncology Institute, Istanbul, Turkey.
- Department of Nuclear Medicine, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey.
- Department of Orthopedics and Traumatology, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey.
ORCID-Profile: Basak Koc, Cuneyt Turkmen, Gokhan Polat, Bulent Zulfikar
Zitieren
APA
Koc, B., Turkmen, C., Polat, G., & Zulfikar, B. (2025). Repeated Radiosynovectomy in Haemophilia: Revealing Long‐Term Effectiveness and Safety. Haemophilia. https://doi.org/10.1111/hae.15142
Vancouver
Koc B, Turkmen C, Polat G, Zulfikar B. Repeated Radiosynovectomy in Haemophilia: Revealing Long‐Term Effectiveness and Safety. Haemophilia. 2025. doi:10.1111/hae.15142
BibTeX
@article{Koc2025,
author = {Koc, Basak and Turkmen, Cuneyt and Polat, Gokhan and Zulfikar, Bulent},
title = {Repeated Radiosynovectomy in Haemophilia: Revealing Long‐Term Effectiveness and Safety},
journal = {Haemophilia},
year = {2025},
doi = {10.1111/hae.15142}
}
EUVIMED